SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.71+1.9%Nov 25 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (6790)1/23/1999 5:26:00 PM
From: BigKNY3  Read Replies (1) of 9523
 
On next week's Washington agenda:

Thursday, Jan. 28

9 a.m.: Advisory panel to the Food and Drug Administration considers a new drug application for Tikosyn capsules (dofetilide) from Pfizer Pharmaceuticals (PFE) for abnormal heart rhythm, at the National Institutes of Health, Bethesda, Md.

BigKNY3
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext